Cargando…

Immunity to RSV in Early-Life

Respiratory Syncytial Virus (RSV) is the commonest cause of severe respiratory infection in infants, leading to over 3 million hospitalizations and around 66,000 deaths worldwide each year. RSV bronchiolitis predominantly strikes apparently healthy infants, with age as the principal risk factor for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lambert, Laura, Sagfors, Agnes M., Openshaw, Peter J. M., Culley, Fiona J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179512/ https://www.ncbi.nlm.nih.gov/pubmed/25324843 http://dx.doi.org/10.3389/fimmu.2014.00466

Ejemplares similares

Innate Immunity to Respiratory Infection in Early Life
por: Lambert, Laura, et al.
Publicado: (2017)

Protective and dysregulated T cell immunity in RSV infection()
por: Openshaw, Peter J, et al.
Publicado: (2013)

Natural killer cell NKG2D and granzyme B are critical for allergic pulmonary inflammation(⋆)
por: Farhadi, Nazanin, et al.
Publicado: (2014)

A Gene Expression Signature for RSV: Clinical Implications and Limitations
por: Openshaw, Peter J. M.
Publicado: (2013)

The Chemokine MIP1α/CCL3 Determines Pathology in Primary RSV Infection by Regulating the Balance of T Cell Populations in the Murine Lung
por: Tregoning, John S., et al.
Publicado: (2010)

Bovine IgG Prevents Experimental Infection With RSV and Facilitates Human T Cell Responses to RSV
por: Nederend, Maaike, et al.
Publicado: (2020)

Current Insights in the Development of Efficacious Vaccines Against RSV
por: Soto, Jorge A., et al.
Publicado: (2020)

Determining Immune and miRNA Biomarkers Related to Respiratory Syncytial Virus (RSV) Vaccine Types
por: Atherton, Lydia J., et al.
Publicado: (2019)

Mucosal immunization with an adenoviral vector vaccine confers superior protection against RSV compared to natural immunity
por: Maier, Clara, et al.
Publicado: (2022)

Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity
por: Hijano, Diego R., et al.
Publicado: (2019)

A Recombinant MVA-Based RSV Vaccine Induces T-Cell and Antibody Responses That Cooperate in the Protection Against RSV Infection
por: Endt, Kathrin, et al.
Publicado: (2022)

Immunity to HIV in Early Life
por: Muenchhoff, Maximilian, et al.
Publicado: (2014)

Delayed Sequelae of Neonatal Respiratory Syncytial Virus Infection Are Dependent on Cells of the Innate Immune System
por: Harker, James A., et al.
Publicado: (2014)

Biology of Infection and Disease Pathogenesis to Guide RSV Vaccine Development
por: Boyoglu-Barnum, Seyhan, et al.
Publicado: (2019)

Age at First Viral Infection Determines the Pattern of T Cell–mediated Disease during Reinfection in Adulthood
por: Culley, Fiona J., et al.
Publicado: (2002)

Alterations in RSV induced pulmonary illness due to mutations in the attachment protein G
por: Sparer, T., et al.
Publicado: (1997)

Early-life microbiota-immune homeostasis
por: Reynolds, Hayley M., et al.
Publicado: (2023)

TLR7 promotes chronic airway disease in RSV-infected mice
por: Miles, Mark A., et al.
Publicado: (2023)

Alveolar macrophage–derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes
por: Goritzka, Michelle, et al.
Publicado: (2015)

Immunity to Cytomegalovirus in Early Life
por: Huygens, Ariane, et al.
Publicado: (2014)

Effect of Infant RSV Infection on Memory T Cell Responses at Age 2-3 Years
por: Chirkova, Tatiana, et al.
Publicado: (2022)

Sublingual Immunization With an RSV G Glycoprotein Fragment Primes IL-17-Mediated Immunopathology Upon Respiratory Syncytial Virus Infection
por: Cheon, In Su, et al.
Publicado: (2019)

RSV Prevention in All Infants: Which Is the Most Preferable Strategy?
por: Esposito, Susanna, et al.
Publicado: (2022)

Case Report: ASCENIV use in three young children with immune abnormalities and acute respiratory failure secondary to RSV infection
por: Bindernagel, Constance, et al.
Publicado: (2023)

Immunogenicity and protective efficacy of an RSV G S177Q central conserved domain nanoparticle vaccine
por: Bergeron, Harrison C., et al.
Publicado: (2023)

Resilience of the respiratory microbiome in controlled adult RSV challenge study
por: Cuthbertson, Leah, et al.
Publicado: (2022)

Toward unified molecular surveillance of RSV: A proposal for genotype definition
por: Goya, Stephanie, et al.
Publicado: (2020)

Soluble Mediators Regulating Immunity in Early Life
por: Pettengill, Matthew Aaron, et al.
Publicado: (2014)

Malaria and Early Life Immunity: Competence in Context
por: Callaway, Perri C., et al.
Publicado: (2021)

The adaptive immune system in early life: The shift makes it count
por: Pieren, Daan K. J., et al.
Publicado: (2022)

The Role of Environmental Factors in Modulating Immune Responses in Early Life
por: MacGillivray, Duncan M., et al.
Publicado: (2014)

RSV Infection in Neonatal Mice Induces Pulmonary Eosinophilia Responsible for Asthmatic Reaction
por: Zhang, Dan, et al.
Publicado: (2022)

MAVS Deficiency Is Associated With a Reduced T Cell Response Upon Secondary RSV Infection in Mice
por: Paulsen, Michelle, et al.
Publicado: (2020)

Editorial: Early Life Origins of Immune-Mediated Disease
por: Skevaki, Chrysanthi, et al.
Publicado: (2020)

ITGB4 Deficiency in Airway Epithelium Aggravates RSV Infection and Increases HDM Sensitivity
por: Du, Xizi, et al.
Publicado: (2022)

Adult Memory T Cell Responses to the Respiratory Syncytial Virus Fusion Protein During a Single RSV Season (2018–2019)
por: Blunck, Brittani N., et al.
Publicado: (2022)

Challenges and Opportunities of Therapies Targeting Early Life Immunity for Pediatric HIV Cure
por: Berendam, Stella J., et al.
Publicado: (2022)

Epigenomics and Early Life Human Humoral Immunity: Novel Paradigms and Research Opportunities
por: Gutierrez, Maria J., et al.
Publicado: (2020)

Role and Diagnostic Performance of Host Epigenome in Respiratory Morbidity after RSV Infection: The EPIRESVi Study
por: Pischedda, Sara, et al.
Publicado: (2022)

Endogenous IL-21 regulates pathogenic mucosal CD4 T-cell responses during enhanced RSV disease in mice
por: Dodd, J S, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_tj6ok1v1hhiio4us9vc75v4461